Bavachalcone

CAS No. 28448-85-3

Bavachalcone( —— )

Catalog No. M24197 CAS No. 28448-85-3

Bavachalcone is a major bioactive compounds isolated from Psoralea corylifolia L.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 112 In Stock
5MG 103 In Stock
10MG 154 In Stock
25MG 278 In Stock
50MG 408 In Stock
100MG 591 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Bavachalcone
  • Note
    Research use only, not for human use.
  • Brief Description
    Bavachalcone is a major bioactive compounds isolated from Psoralea corylifolia L.
  • Description
    Bavachalcone is a major bioactive compounds isolated from Psoralea corylifolia L. it may be useful as a therapeutic drug for bone resorption-associated diseases.Bavachalcone can protect the endothelial function by increasing AMPK activity and MnSOD expression and reducing mitochondrial oxidative stress.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    GPCR/G Protein
  • Target
    Antibacterial
  • Recptor
    Bacterial
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    28448-85-3
  • Formula Weight
    324.4
  • Molecular Formula
    C20H20O4
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:34 mg/mL?(104.82 mM)
  • SMILES
    O=C(C1=CC(C/C=C(C)\C)=C(O)C=C1O)/C=C/C2=CC=C(O)C=C2
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Comparison of the Inhibitory Potential of Bavachalcone and Corylin against UDP-Glucuronosyltransferases. Evid Based Complement Alternat Med. 2014;2014:958937.
molnova catalog
related products
  • AN12855

    AN12855 (AN-12855) is potent, cofactor-independent M. tuberculosis InhA inhibitor, binds to and inhibits InhA with IC50 of 0.03 uM.

  • Chikusetsusaponin IV...

    Chikusetsusaponin IVa is a novel AMPK activator, can induce insulin secretion from βTC3 cells via GPR4 mediated calcium and PKC pathways.

  • JCP251

    JCP251 is a selective small molecule inhibitor of S. aureus serine hydrolase FphB, effectively reduces infectivity in vivo.